Skip to content
Open access

Adeno-associated Virus (AAV) Synthetic Inverted Terminal Repeat Enhances Tissue Specific Transduction and Altered Vector Induced Stress Response

Jul 2026 · bioRxiv · 0 citations
Biology

TL;DR

Data demonstrate that SynITRs elicit tissue-specific transduction enhancement and alter the cellular stress response and offer an alternative context to elucidate wtITR biology for targeted, enhanced, and potentially safer human gene therapy.

Read PDF

Similar papers

Review Open access Jul 2026

AAV Vectors in Regenerative Medicine and Cellular Reprogramming: Potential, Pitfalls, and Specificity Constraints

Evidence that cell-type-specific promoters lose fidelity when paired with neurogenic transgene payloads and that published in vivo reprogramming efficiencies may be substantially confounded by promoter leakage in the absence of formal lineage tracing are synthesized.

M. Abdelnaby, A. Galiakberova, E. Dashinimaev · 0 citations
Open access Jul 2026

AAV Vector Toolkit for the Delivery and Expression of the Artificial microRNA in the Murine Heart

It is shown that systemic AAV administration provides potent delivery and uniform transduction of cardiac tissue, outperforming localized injection techniques and establishing an effective AAV approach for transgene transfer into the mouse heart and promote the development of gene therapy for cardiac disorders.

I. Galkin, V. Skopenkova, Maria Y. Shubina et al. · 0 citations
Open access Jul 2026

Genome-Wide Characterization of Recombinant AAV6 Vector Integration in Human CD34+ Cells.

The data support the genomic safety of rAAV6 and its applicability to hematological gene therapy and functional enrichment analysis indicated associations with general cellular and structural processes, without enrichment in oncogenic pathways.

H. Lee, Nayoung Park, In-Byung Park et al. · 0 citations
Open access Jul 2026

A novel adeno-associated viral vector derived from human spleen isolate AAV.hu.S17

This study generated a novel recombinant AAV vector rAAV.hu.hu.S17, derived from the human spleen isolate AAV.hu.S17, and systematically evaluated its capsid features, in vitro transduction, and in vivo tissue tropism.

Wenyan Guo, Jiawen Sun, Fei Wang et al. · 0 citations
Aug 2026

Leveraging host cell modulators of adeno-associated vectors transduction to tailor viral biodistribution.

A novel approach to detarget liver transduction is developed by transiently downregulating the expression of key entry factors in this tissue using GalNac-siRNAs prior to AAV9 administration, which blunted hepatic transduction but also redirected the vector to other transduction-permissive tissues.

K. Kubek-Luck, J. Velazquez, Xiao-Rui Yao et al. · 0 citations
Open access Jul 2026

A Modular Polymer Enhancer Promotes AAV Transduction and Circumvents Preexisting Immunity in Nonhuman Primates.

Adeno-associated virus (AAV) gene therapy is frequently hindered by dose-limiting toxicities and preexisting neutralizing antibodies (nAbs). Here, we evaluate enhancer polymer (ePL), a cargo-less poly(L-lactic-co-glycolic acid) nanoparticle, the systemic administration of which demonstrated biocompatibility in nonhuman...

Lauren Switala, A. Khandaker, Sumita Dutta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.